Erythema Multiforme - 25 Studies Found
Completed |
: Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05% : Plaque Psoriasis : 2013-06-26 : Drug: Clobex Spray Other Name: Clobetasol propionate spray |
Recruiting |
: A Randomized Two Arm Phase II Trial of Pembrolizumab Alone or Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC : Stage IV Non-Small Cell Lung Cancer : 2016-01-14 :
|
Not yet recruiting |
: Discerning Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Guided Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy :
|
Completed |
: Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer : Head and Neck Cancer : 2001-08-10 : Drug: liposomal lurtotecan |
Active, not recruiting |
: Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis (Dialysis Fistulae) :
|
Recruiting |
: Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study : Toxic Epidermal Necrolysis : 2016-06-06 :
|
Recruiting |
: Severe Cutaneous Adverse Reactions in Thailand :
|
Recruiting |
: HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction :
: 2017-02-06 : Genetic: HLA-B*5801 test Check whether a participant has HLA-B*5801 allele or not, before administration |
Not yet recruiting |
: Cyclosporine and Etanercept in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis :
: 2016-11-25 :
|
Active, not recruiting |
: Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation :
|